Akerblom, H. K., Vaarala, O., Hyoty, H., et al (2002) Environmental factors in the etiology of type 1 diabetes. American Journal of Medical Genetics, 115, 18–29.
Alberti, K. G. & Zimmet, P. Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539–553.
Allison, D. B. & Casey, D. E. (2001) Antipsychotic-induced weight gain: a review of the literature. Journal of Clinical Psychiatry, 62 (suppl. 7), 22–31.
American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Diabetes Care, 23, 381–389.
American Diabetes Association (2001) Diabetes 2001 Vital Statistics. Alexandria, VA: ADA.
American Diabetes Association (2002) The prevention or delay of type 2 diabetes. Diabetes Care, 25, 742–749.
Assmann, G. & Schulte, H. (1988) The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. American Heart Journal, 116, 1713–1724.
Barnett, A. H., Eff, C., Leslie, R. D., et al (1981) Diabetes in identical twins. A study of 200 pairs. Diabetologia, 20, 87–93.
Bennett, N., Dodd, T., Flatley, J., et al (1995) Health Survey for England 1993. London: HMSO.
Bloom, A., Hayes, T. M. & Gamble, D. R. (1975) Register of newly diagnosed diabetic children. BMJ, 13, 580–583.
Boulton, A. J. & Malik, R. A. (1998) Diabetic neuropathy. Medical Clinics of North America, 82, 909–929.
Buchanan, T. A., Xiang, A. H., Peters, R. K., et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes, 51, 2796–2803.
Bushe, C. & Holt, R. (2004) Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. British Journal of Psychiatry, 184 (suppl. 47), s67–s71.
Carey, V. J., Walters, E. E., Colditz, G. A., et al (1997) Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. American Journal of Epidemiology, 145, 614–619.
Chiasson, J. L., Josse, R. G., Gomis, R., et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet, 359, 2072–2077.
Colditz, G. A., Willett, W. C., Rotnitzky, A., et al (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Annals of Internal Medicine, 122, 481–486.
DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Archives of Internal Medicine, 161, 397–405.
DeFronzo, R. A. (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 37, 667–687.
DeFronzo, R. A. & Ferrannini, E. (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173–194.
EURODIAB ACE Study Group (2000) Variation and trends in incidence of childhood diabetes in Europe. Lancet, 355, 873–876.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1183–1197.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486–2497.
Ford, E. S., Giles, W. H. & Dietz, W. H. (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 287, 356–359.
Gough, S. & Peveler, R. (2004) Diabetes and its prevention: pragmatic solutions for people with schizophrenia. British Journal of Psychiatry, 184 (suppl. 47), s106–s111.
Haddad, P. M. (2004) Antipsychotics and diabetes: review of non-prospective data. British Journal of Psychiatry, 184 (suppl 47), s80–s86.
Haffner, S. M., Lehto, S., Ronnemaa, T., et al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine, 339, 229–234.
Hales, C. N., Barker, D. J., Clark, P. M., et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ, 303, 1019–1022.
Holman, R. R. (1998) Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Research and Clinical Practice, 40 (suppl), S21–S25.
Holt, R. I. G., Peveler, R. C. & Byrne, C. D. (2004) Schizophrenia, the metabolic syndrome and diabetes. Diabetes Medicine, in press.
Hu, F. B., Sigal, R. J., Rich Edwards, J. W., et al (1999) Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA, 282, 1433–1439.
Jin, H., Meyer, J. M. & Jeste, D. V. (2002) Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Annals of Clinical Psychiatry, 14, 59–64.
Jonsson, B. (2002) Revealing the cost of type II diabetes in Europe. Diabetologia, 45, S5–S12.
Kahn, C. R. (1978) Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism: Clinical and Experimental, 27, 1893–1902.
Karvonen, M., Pitkaniemi, J. & Tuomilehto, J. (1999) The onset age of type I diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care, 22, 1066–1070.
Knowler, W. C., Barrett Connor, E., Fowler, S. E., et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393–403.
Lean, M. E. (2000) Obesity: burdens of illness and strategies for prevention or management. Drugs Today
Liu, D. P., Molyneaux, L., Chua, E., et al (2002) Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Research and Clinical Practice, 56, 125–131.
Maison, P., Byrne, C. D., Hales, C. N., et al (2001) Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care, 24, 1758–1763.
Malmberg, K., Ryden, L., Efendic, S., et al (1995) Randomized trial of insulin–glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. Journal of the American College of Cardiology, 26, 57–65.
Mather, H. M. & Keen, H. (1985) The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. BMJ, 291, 1081–1084.
Moller, D. E. & Flier, J. S. (1991) Insulin resistance – mechanisms, syndromes, and implications. New England Journal of Medicine, 325, 938–948.
National Task Force on the Prevention and Treatment of Obesity (2000) Overweight, obesity, and health risk. Archives of Internal Medicine, 160, 898–904.
Neil, H. A., Gatling, W., Mather, H. M., et al (1987) The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabetic Medicine, 4, 539–543.
Newsome, C. A., Shiell, A. W., Fall, C. H., et al (2003) Is birth weight related to later glucose and insulin metabolism? A systematic review. Diabetic Medicine, 20, 339–348.
Pan, X. R., Li, G. W., Hu, Y. H., et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 20, 537–544.
Pettitt, D. J., Knowler, W. C., Lisse, J. R., et al (1980) Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet, ii, 1050–1052.
Pettitt, D. J., Nelson, R. G., Saad, M. F., et al (1993) Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care, 16, 310–314.
Phillips, D. I., Barker, D. J., Hales, C. N., et al (1994) Thinness at birth and insulin resistance in adult life. Diabetologia, 37, 150–154.
Pratley, R. E. & Weyer, C. (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia, 44, 929–945.
Prentki, M., Joly, E., El Assaad, W., et al (2002) Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes, 51 (suppl. 3), S405–S413.
Reaven, G. M. (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595–1607.
Saad, M. F., Knowler, W. C., Pettitt, D. J., et al (1988) The natural history of impaired glucose tolerance in the Pima Indians. New England Journal of Medicine, 319, 1500–1506.
Sowell, M. O., Mukhopadhyay, N., Cavazzoni, P., et al (2002) Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. Journal of Clinical Endocrinology and Metabolism, 87, 2918–2923.
Stamler, J., Vaccaro, O., Neaton, J. D., et al (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16, 434–444.
Stratton, I. M., Adler, A. I., Neil, H. A., et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 321, 405–412.
Thomas, F., Balkau, B., Vauzelle Kervroedan, F., et al (1994) Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB–INSERM–ZENECA Study Group. Diabetes, 43, 63–67.
Torgerson, J. S., Hauptman, J., Boldrin, M. N., et al (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27, 155–161.
Tuomilehto, J., Lindstrom, J., Eriksson, J. G., et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344, 1343–1350.
UK Prospective Diabetes Study Group (1988) Prospective Diabetes Study IV. Characteristics of newly presenting type 2 diabetic patients: male preponderance and obesity at different ages. Multicenter Study. Diabetic Medicine, 5, 154–159.
UK Prospective Diabetes Study Group (1995) UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes, 44, 1249–1258.
Wareham, N. J. & Griffin, S. J. (2001) Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ, 322, 986–988.
West, K. M. (1975) Substantial differences in the diagnostic criteria used by diabetes experts. Diabetes, 24, 641–644.
Williams, D. R., Wareham, N. J., Brown, D. C., et al (1995) Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabetic Medicine, 12, 30–35.
World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. WHO/NCD/NCS/99.2. Geneva: WHO.
World Health Organization/International Diabetes Federation (1999) The Economics of Diabetes and Diabetes Care: A Report of the Diabetes Health Economics Study Group. Geneva: WHO/IDF.
Wylie, G., Hungin, A. P. & Neely, J. (2002) Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions. BMJ, 324, 1190.
Zimmet, P. (1982) Type 2 (non-insulin-dependent) diabetes – an epidemiological overview. Diabetologia, 22, 399–411.
Zimmet, P., Shaw, J. & Alberti, K. G. M. M. (2003) Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabetic Medicine, 20, 693–702.